Shares of Abcam plc (NASDAQ:ABCM – Get Free Report) have received a consensus rating of “Hold” from the six brokerages that are covering the firm, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month target price among […]
Shares of Abcam plc (NASDAQ:ABCM – Get Free Report) saw strong trading volume on Thursday . 5,111,703 shares were traded during mid-day trading, an increase of 85% from the previous session’s volume of 2,758,385 shares.The stock last traded at $23.15 and had previously closed at $23.26. Wall Street Analyst Weigh In Several analysts recently weighed […]
Abcam (NASDAQ:ABCM – Get Free Report) and BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk. Insider & Institutional Ownership 90.5% of Abcam shares are […]
Shares of Abcam plc (LON:ABC – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,226 ($14.92) and traded as low as GBX 1,115 ($13.57). Abcam shares last traded at GBX 1,226 ($14.92), with a volume of 6,372,291 shares. Abcam Stock […]
National Bank of Canada FI grew its position in shares of Abcam plc (NASDAQ:ABCM – Free Report) by 267.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 309,692 shares of the company’s stock after acquiring an additional 225,460 shares during the quarter. National […]